We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Simple Test Saves the Lives of Newborns with Congenital Heart Disease

By HospiMedica International staff writers
Posted on 27 Oct 2011
The United States, Singapore, Vietnam, Argentina, and other countries are set to support compulsory pulse oximetry (SpO2) screening of newborns for duct dependent congenital heart disease (CHD) before leaving hospital.

The decisions are being based on the findings of the now famous “Swedish study,” published in January 2009 in BMJ, which showed that mortality among infants discharged with an undiagnosed critical heart defect was 18%, or around one in six children, but only 0.9% for those diagnosed using SpO2 before leaving hospital. More...
As a result, several counties in Sweden have already introduced the test, although as yet there is no coordinated national recommendation. Additionally, all newborns in Beijing (China) are already being screened, and other countries are set to make the test mandatory.

The researchers at the University of Gothenburg (Sweden), and Queen Silvia Children's Hospital (Göteborg, Sweden) conducted their study between 2004 and 2009, performing a pulse oximetry test before discharge from well baby nurseries in the district of West Götaland. The cohort study compared the detection rate of duct dependent circulation in the district with that in other regions that are not using pulse oximetry screening. The results showed that no baby died from undiagnosed duct dependent circulation in West Götaland, versus five deaths babies from the other referring regions.

“People around the world are now talking about `the Swedish study,´ and I've been invited to Nanjing in China to help start up a screening program there this autumn,” said the study’s lead author Anne de-Wahl Granelli, MD. “I'm absolutely delighted that the research has had such an impact. My colleagues and everyone else who helped us with the clinical side of the study over a three-and-a-half-year period all deserve a share of the credit for the attention it has been given worldwide.”

Pulse oximetry is a noninvasive test that is applied to the right hand and a foot of a newborn, to get two different readings of oxygen levels in the blood. Testing should ideally be done after the baby is 24 hours old, since changes in the circulatory system during very early in life can cause a false positive result. A low SpO2 level can result from CHD, infections, or other serious health problems. Congenital heart diseases are responsible for more deaths in the first year of life than any other birth defect, but outcomes can often be improved with early detection.

Related Links:
University of Gothenburg
Queen Silvia Children's Hospital



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.